We would like to inform people with epilepsy and their family members that there is currently a supply issue being experienced with the Ant-Seizure Medication, Epanutin 50mg hard capsules.
According to the Health Products Regulatory Authority (HPRA), the shortage is due to manufacturing delays. The shortage was first listed on the 1st of December and is expected to continue until mid-March 2023.
We have contacted the HPRA regarding this shortage and should further information become available regarding this shortage, we will provide a further update on our website.
In the meantime, if you have been affected by this shortage or are concerned, please contact your medical team for further advice.
You can find further information on medication supply issues by visiting the 'Treatment' section of our website.